5//SEC Filing
Q Therapeutics, Inc. 5
Accession 0001209191-13-040378
CIK 0001366541operating
Filed
Aug 12, 8:00 PM ET
Accepted
Aug 13, 12:49 PM ET
Size
5.8 KB
Accession
0001209191-13-040378
Insider Transaction Report
Form 5
Q Therapeutics, Inc.[NONE]
EPPSTEIN DEBORAH ANNE
CEO & President, Director
Transactions
- Award
Options to Purchase Common Stock
2012-03-28$1.00/sh+250,000$250,000→ 1,647,477 totalExercise: $1.00From: 2012-03-28Exp: 2022-03-27→ Common Stock (250,000 underlying)
Footnotes (1)
- [F1]Granted options to purchase common stock subject to vesting. Options were 3/48 vested immediately upon grant, with vesting spread evenly over the remaining 45 months.
Documents
Issuer
Q Therapeutics, Inc.
CIK 0001366541
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001366541
Filing Metadata
- Form type
- 5
- Filed
- Aug 12, 8:00 PM ET
- Accepted
- Aug 13, 12:49 PM ET
- Size
- 5.8 KB